UnknownNot Applicable

Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy

Denmark33 participantsStarted 2019-01-30

Plain-language summary

The objective of the study is to investigate the development of NAFLD following total pancreatectomy and pancreaticoduodenectomy and to explore the histological and metabolic changes following the procedures.

Who can participate

Age range

18 Years – 79 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject scheduled for total pancreatectomy or pancreaticoduodenectomy * Informed consent signed prior to any study-related procedure Exclusion Criteria: * Known liver disease before total pancreatectomy or pancreaticoduodenectomy (excluding NAFLD) * Severe co-morbid disease (besides from the indication for the pancreas surgery) * Pregnancy * Any condition that the investigator feels would interfere with the safety of the trial participation or the safety of the subject * Metastatic disease Percutaneous liver biopsy exclusion criteria (to be evaluated before last visit) * MR spectroscopy demonstrating lipid content \<2% * Haemoglobin \<6 mmol/L * INR \>1.5 * Trombocytes \<40 × 109/L * Skin infection in area where biopsy will be sampled

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in hepatic lipid content (steatosis) after total pancreatektomy or pancreaticoduodenectomy

Timeframe: Baseline and after 12 months.

Trial details

NCT IDNCT03864744

SponsorSteno Diabetes Center Copenhagen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-08-30

View on ClinicalTrials.gov More Total Pancreatectomy trials

Who can participate

Age range

18 Years – 79 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.